Financhill
Back

Prenetics Global Quote, Financials, Valuation and Earnings

Prenetics Global Price Quote

$4.81
+0.31 (+6.89%)
(Updated: November 27, 2024 at 1:05 PM ET)

Prenetics Global Key Stats

Sell
36
Prenetics Global (PRE) is a Sell

Day range:
$4.50 - $4.63
52-week range:
$2.85 - $7.84
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
2.41
P/B ratio:
0.29%

Volume:
6.2K
Avg. volume:
6.5K
1-year change:
-1.53%
Market cap:
$55M
Revenue:
$21.7M
EPS:
$-4.35

How Much Does Prenetics Global Make?

Is Prenetics Global Growing As A Company?

  • What Is Prenetics Global's Growth Rate Quarterly?
    Quarterly YoY revenue growth is -0.09%
  • What Is Prenetics Global's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Prenetics Global Stock Price Performance

  • Did Prenetics Global Stock Go Up Last Month?
    Prenetics Global share price went down by -3.43% last month
  • Did PRE's Share Price Rise Over The Last Year?
    PRE share price fell by -1.53% over the past 1 year

What Is Prenetics Global 52-Week High & Low?

Prenetics Global Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Prenetics Global?

  • How Much Debt Does Prenetics Global Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Prenetics Global Have?
    Cash and short term investments quarterly total is $52.1M
  • What Is Prenetics Global’s Book Value Per Share?
    Book value per share is 15.41

Is Prenetics Global Cash Flow Positive?

Data Unavailable

Prenetics Global Return On Invested Capital

  • Is Management Doing A Good Job?
    PRE return on invested capital is -23.65%
  • What Is Prenetics Global Return On Assets?
    ROA measures how assets are converting to revenues and is -19.33%
  • What Is PRE Return On Equity?
    ROE is a measure of profitability and is -23.65%

Prenetics Global Earnings Date & Stock Price

Prenetics Global Competitors

  • Who Are Prenetics Global's Competitors?
    Below is a list of companies who compete with Prenetics Global or are related in some way:
    • HUTCHMED (China) Ltd (HCM)
    • Pharmaron Beijing Co Ltd (PHBBF)
    • Regencell Bioscience Holdings Ltd (RGC)
    • Sino Biopharmaceutical Ltd (SBMFF)
    • Uni-Bio Science Group Ltd (UNBSF)

Prenetics Global Dividend Yield

Prenetics Global Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: -8.75% -22.84%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 9.00
Upside from Last Price: 100%

Major Shareholders

  • How many PRE shares are owned by institutional investors?
    1.9M PRE shares are owned by institutional investors
  • How many PRE shares are owned by insiders?
    0 PRE shares are owned by insiders